267 related articles for article (PubMed ID: 17207880)
21. Noncovalent pegylation by dansyl-poly(ethylene glycol)s as a new means against aggregation of salmon calcitonin.
Mueller C; Capelle MA; Arvinte T; Seyrek E; Borchard G
J Pharm Sci; 2011 May; 100(5):1648-62. PubMed ID: 21374604
[TBL] [Abstract][Full Text] [Related]
22. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
[TBL] [Abstract][Full Text] [Related]
23. Oral delivery of mono-PEGylated sCT (Lys18) in rats: regional difference in stability and hypocalcemic effect.
Mansoor S; Youn YS; Lee KC
Pharm Dev Technol; 2005; 10(3):389-96. PubMed ID: 16176019
[TBL] [Abstract][Full Text] [Related]
24. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).
Na DH; DeLuca PP
Pharm Res; 2005 May; 22(5):736-42. PubMed ID: 15906168
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic disposition of polyethylene glycol-modified salmon calcitonins in rats.
Yoo SD; Jun H; Shin BS; Lee HS; Park MO; Deluca PP; Lee KC
Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):1921-4. PubMed ID: 11145145
[TBL] [Abstract][Full Text] [Related]
26. Identification of the modifying sites of mono-PEGylated salmon calcitonins by capillary electrophoresis and MALDI-TOF mass spectrometry.
Na DH; Park MO; Choi SY; Kim YS; Lee SS; Yoo SD; Lee HS; Lee KC
J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(1):259-63. PubMed ID: 11318423
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of salmon calcitonin-biotin conjugates.
Cetin M; Youn YS; Capan Y; Lee KC
AAPS PharmSciTech; 2008; 9(4):1191-7. PubMed ID: 19082740
[TBL] [Abstract][Full Text] [Related]
28. Degradation of salmon calcitonin in rat kidney and liver homogenates.
Liao S; Zhang ZQ; Ruan JX; Qi JK; Liu KL
Pharmazie; 2008 Oct; 63(10):743-7. PubMed ID: 18972837
[TBL] [Abstract][Full Text] [Related]
29. PEGylation of octreotide: II. Effect of N-terminal mono-PEGylation on biological activity and pharmacokinetics.
Na DH; Lee KC; DeLuca PP
Pharm Res; 2005 May; 22(5):743-9. PubMed ID: 15906169
[TBL] [Abstract][Full Text] [Related]
30. Direct peptide bioconjugation/PEGylation at tyrosine with linear and branched polymeric diazonium salts.
Jones MW; Mantovani G; Blindauer CA; Ryan SM; Wang X; Brayden DJ; Haddleton DM
J Am Chem Soc; 2012 May; 134(17):7406-13. PubMed ID: 22494012
[TBL] [Abstract][Full Text] [Related]
31. Tryptophan-mPEGs: novel excipients that stabilize salmon calcitonin against aggregation by non-covalent PEGylation.
Mueller C; Capelle MA; Arvinte T; Seyrek E; Borchard G
Eur J Pharm Biopharm; 2011 Nov; 79(3):646-57. PubMed ID: 21703347
[TBL] [Abstract][Full Text] [Related]
32. A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: chondro-protective effect in a rabbit model of early OA.
Mero A; Campisi M; Favero M; Barbera C; Secchieri C; Dayer JM; Goldring MB; Goldring SR; Pasut G
J Control Release; 2014 Aug; 187():30-8. PubMed ID: 24837189
[TBL] [Abstract][Full Text] [Related]
33. Chemical and enzymatic site specific PEGylation of hGH.
da Silva Freitas D; Mero A; Pasut G
Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
[TBL] [Abstract][Full Text] [Related]
34. Aqueous-soluble, non-reversible lipid conjugate of salmon calcitonin: synthesis, characterization and in vivo activity.
Cheng W; Satyanarayanajois S; Lim LY
Pharm Res; 2007 Jan; 24(1):99-110. PubMed ID: 17109213
[TBL] [Abstract][Full Text] [Related]
35. Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues.
Hu J; Duppatla V; Harth S; Schmitz W; Sebald W
Bioconjug Chem; 2010 Oct; 21(10):1762-72. PubMed ID: 20886828
[TBL] [Abstract][Full Text] [Related]
36. Capillary electrophoretic characterization of PEGylated human parathyroid hormone with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Na DH; Lee KC
Anal Biochem; 2004 Aug; 331(2):322-8. PubMed ID: 15265738
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity.
Hu X; Xu B; Zhou Z
AAPS PharmSciTech; 2015 Oct; 16(5):1213-9. PubMed ID: 25761386
[TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of monomethoxypoly(ethylene glycol)-insulin conjugates.
Zhang M; Dou H; Yin L; Zhang Y; Zhu S; Yin C
Pharmazie; 2009 Mar; 64(3):190-6. PubMed ID: 19348342
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo characterisation of PEG-lipid-based micellar complexes of salmon calcitonin for pulmonary delivery.
Baginski L; Gobbo OL; Tewes F; Salomon JJ; Healy AM; Bakowsky U; Ehrhardt C
Pharm Res; 2012 Jun; 29(6):1425-34. PubMed ID: 22322897
[TBL] [Abstract][Full Text] [Related]
40. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
